FDA Global Pharma Safety Plan Looks To Food Model
This article was originally published in The Tan Sheet
Executive Summary
FDA seeks new authority over the international drug supply chain to support a global safety plan.
You may also be interested in...
FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports
FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.
FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports
FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.
IOM Pushes For FDA Collaboration With Foreign Regulators
In a report on how FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad, the Institute of Medicine recommends the agency provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.